Fayez Sarofim & CO Viatris Inc Transaction History

Fayez Sarofim & CO

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$9.2 - $12.26 $1,426 - $1,900	155 Added 1.47%	10,666 $102,000
Q4 2022 Feb 13, 2023	SELL	$8.72 - $11.56 $58,642 - $77,741	-6,725 Reduced 39.02%	10,511 $116,000
Q3 2022 Nov 14, 2022	SELL	$8.48 - $11.13 $437,652 - $574,419	-51,610 Reduced 74.96%	17,236 $147,000
Q2 2022 Aug 12, 2022	SELL	$9.95 - $12.27 $56,416 - $69,570	-5,670 Reduced 7.61%	68,846 $720,000
Q1 2022 May 16, 2022	BUY	$9.81 - $15.4 $14,067 - $22,083	1,434 Added 1.96%	74,516 $811,000
Q4 2021 Feb 11, 2022	SELL	$12.09 - $14.68 $12 - $14	-1 Reduced -0.0%	73,082 $988,000
Q3 2021 Nov 15, 2021	SELL	$13.25 - $15.13 $38,968 - $44,497	-2,941 Reduced 3.87%	73,083 $990,000
Q2 2021 Aug 13, 2021	SELL	$12.97 - $16.15 $17,846 - $22,222	-1,376 Reduced 1.78%	76,024 $1.09 Million
Q1 2021 May 13, 2021	SELL	$13.59 - $18.54 $120,366 - $164,208	-8,857 Reduced 10.27%	77,400 $1.08 Million
Q4 2020 Feb 11, 2021	BUY	$14.3 - $18.74 $1.23 Million - $1.62 Million	86,257 New	86,257 $1.62 Million

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.2B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Fayez Sarofim & CO, based on Form 13F filings with the SEC.

Stay updated on Fayez Sarofim & CO with notifications on news.